Skip to main content
Premium Trial:

Request an Annual Quote

Matritech, Bruker Daltonics To Develop Mass Spec For Cancer Diagnostics

NEW YORK, May 20-Bruker Daltonics and Matritech said today that they will work together to develop an automated mass spectrometer for proteomics-based clinical cancer diagnostics.


The two companies will partner to adapt Bruker's MALDI-TOF spectrometer technology to perform tests for the early detection of prostate and breast cancer.


The resulting system will be "turn-key," said Matritech COO and president David Corbet in a statement, allowing clinical laboratories to deliver the company's proprietary tests to market quickly.


Financial details were not disclosed.


Matritech, based in Newton, Mass., develops proteomics-based diagnostics for early cancer detection. The company has identified markers associated with breast, bladder, prostate, cervical and colon cancers, and has a bladder cancer test currently on the market. The company is publicly owned.


Bruker Daltonics, based in Billerica, Mass., is a major provider of mass spectrometry and analysis systems.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.